Triple-negative breast cancer (TNBC) is an aggressive clinical phenotype characterized by the lack of expression (or minimal expression) of the estrogen receptor (ER) and progesterone receptor (PR) as well as the absence of the human epidermal growth factor receptor-2 (HER2). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.